FI114610B - Menetelmä beta-fenyylipropiofenonijohdannaisia sisältävien retardmikrotablettien valmistamiseksi - Google Patents

Menetelmä beta-fenyylipropiofenonijohdannaisia sisältävien retardmikrotablettien valmistamiseksi Download PDF

Info

Publication number
FI114610B
FI114610B FI954686A FI954686A FI114610B FI 114610 B FI114610 B FI 114610B FI 954686 A FI954686 A FI 954686A FI 954686 A FI954686 A FI 954686A FI 114610 B FI114610 B FI 114610B
Authority
FI
Finland
Prior art keywords
active ingredient
weight
release
tablets
tablet
Prior art date
Application number
FI954686A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954686A0 (fi
FI954686A (fi
Inventor
Volker Buehler
Karl Kolter
Helmut Fricke
Herbert Mueller-Peltzer
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6484646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI114610(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of FI954686A0 publication Critical patent/FI954686A0/fi
Publication of FI954686A publication Critical patent/FI954686A/fi
Application granted granted Critical
Publication of FI114610B publication Critical patent/FI114610B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FI954686A 1993-04-03 1995-10-02 Menetelmä beta-fenyylipropiofenonijohdannaisia sisältävien retardmikrotablettien valmistamiseksi FI114610B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4310963 1993-04-03
DE4310963A DE4310963C2 (de) 1993-04-03 1993-04-03 Retardmikrotablette von beta-Phenylpropiophenonderivaten
EP9400949 1994-03-24
PCT/EP1994/000949 WO1994022434A1 (de) 1993-04-03 1994-03-24 RETARDMIKROTABLETTE VON β-PHENYLPROPIOPHENONDERIVATEN

Publications (3)

Publication Number Publication Date
FI954686A0 FI954686A0 (fi) 1995-10-02
FI954686A FI954686A (fi) 1995-10-02
FI114610B true FI114610B (fi) 2004-11-30

Family

ID=6484646

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954686A FI114610B (fi) 1993-04-03 1995-10-02 Menetelmä beta-fenyylipropiofenonijohdannaisia sisältävien retardmikrotablettien valmistamiseksi

Country Status (28)

Country Link
US (1) US5681588A (da)
EP (1) EP0691843B1 (da)
JP (1) JP3625825B2 (da)
KR (1) KR100315618B1 (da)
CN (1) CN1092957C (da)
AT (1) ATE148988T1 (da)
AU (1) AU678227B2 (da)
BR (2) BR9406036A (da)
CA (1) CA2158166C (da)
CZ (1) CZ284869B6 (da)
DE (2) DE4310963C2 (da)
DK (1) DK0691843T3 (da)
ES (1) ES2098930T3 (da)
FI (1) FI114610B (da)
GR (1) GR3023339T3 (da)
HR (1) HRP940198B1 (da)
HU (1) HU221590B (da)
IL (2) IL109097A0 (da)
NO (1) NO306848B1 (da)
NZ (1) NZ263565A (da)
PL (1) PL175219B1 (da)
RU (1) RU2157191C2 (da)
SG (1) SG43955A1 (da)
SI (1) SI9420027A (da)
TW (1) TW266159B (da)
UA (1) UA40616C2 (da)
WO (1) WO1994022434A1 (da)
ZA (1) ZA942293B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
US20050226923A1 (en) * 2004-04-07 2005-10-13 Gassert Chad M Venlafaxine compositions in the form of microtablets
CA2469339A1 (en) * 2004-06-07 2005-12-07 Bernard Charles Sherman Sustained release propafenone hydrochloride capsules
CA2469327A1 (en) * 2004-06-07 2005-12-07 Bernard Charles Sherman Propafenone hydrochloride capsules containing microtablets
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
JP5628480B2 (ja) 2006-03-09 2014-11-19 グラクソスミスクライン エルエルシー 医薬成分を含有するコーティングカプセル
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
US20090035370A1 (en) * 2007-08-02 2009-02-05 Drugtech Corporation Dosage form and method of use
WO2010043950A2 (en) 2008-10-15 2010-04-22 Aizant Drug Research Solutions Private Limited Propafenone extended release composition
CN103908443A (zh) * 2013-11-25 2014-07-09 力品药业（厦门）有限公司 一种盐酸普罗帕酮缓释胶囊及其制备方法
CN107441051B (zh) * 2016-05-30 2022-09-16 北京科信必成医药科技发展有限公司 一种盐酸普罗帕酮微片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951821A (en) * 1972-07-14 1976-04-20 The Dow Chemical Company Disintegrating agent for tablets
DE3210061A1 (de) * 1982-03-19 1983-09-22 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von propafenon
DE3422619A1 (de) * 1984-06-19 1985-12-19 Basf Ag, 6700 Ludwigshafen Zylindrische mikrotabletten
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
DE3725273A1 (de) * 1987-07-30 1989-02-09 Basf Ag Verfahren zur synthese von enantiomeren des propafenons sowie diese enthaltende therapeutische mittel
DE3809764A1 (de) * 1988-03-23 1989-10-05 Knoll Ag Mischung aus alginaten und polyacrylaten und deren verwendung
US4954347A (en) * 1988-05-03 1990-09-04 Basf K & F Corp. Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
DE3911069A1 (de) * 1989-04-06 1990-10-11 Knoll Ag Einkristalle von ss-phenylpropiophenonen
HU219341B (en) * 1990-07-02 2001-03-28 Roche Diagnostics Gmbh Process for producing pressed, moulded, delayed release dose units and dose units thus produced
DE4021678C2 (de) * 1990-07-07 1994-07-07 Merz & Co Gmbh & Co Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen
IT1250483B (it) * 1990-08-30 1995-04-07 Eurand Int Sistema di ritardo a matrice multipla

Also Published As

Publication number Publication date
SI9420027A (en) 1996-08-31
CA2158166C (en) 2003-10-21
IL109097A (en) 1998-09-24
HRP940198B1 (en) 1997-12-31
ATE148988T1 (de) 1997-03-15
CZ246595A3 (en) 1996-02-14
NO306848B1 (no) 2000-01-03
KR960701630A (ko) 1996-03-28
ZA942293B (en) 1995-10-02
EP0691843B1 (de) 1997-02-19
TW266159B (da) 1995-12-21
NZ263565A (en) 1996-08-27
JP3625825B2 (ja) 2005-03-02
NO953910L (no) 1995-10-02
AU678227B2 (en) 1997-05-22
NO953910D0 (no) 1995-10-02
BR9406036A (pt) 1995-12-12
PL175219B1 (pl) 1998-11-30
US5681588A (en) 1997-10-28
HRP940198A2 (en) 1996-10-31
EP0691843A1 (de) 1996-01-17
WO1994022434A1 (de) 1994-10-13
SG43955A1 (en) 1997-11-14
ES2098930T3 (es) 1997-05-01
RU2157191C2 (ru) 2000-10-10
CN1120312A (zh) 1996-04-10
HU9502879D0 (en) 1995-11-28
PL310966A1 (en) 1996-01-22
IL109097A0 (en) 1994-06-24
CA2158166A1 (en) 1994-10-13
BR1100303A (pt) 2002-04-02
UA40616C2 (uk) 2001-08-15
FI954686A0 (fi) 1995-10-02
HU221590B (hu) 2002-11-28
DE4310963A1 (de) 1994-10-06
FI954686A (fi) 1995-10-02
DE59401833D1 (de) 1997-03-27
CZ284869B6 (cs) 1999-03-17
HUT73248A (en) 1996-07-29
GR3023339T3 (en) 1997-08-29
JPH08508010A (ja) 1996-08-27
CN1092957C (zh) 2002-10-23
DE4310963C2 (de) 1997-06-05
AU6429594A (en) 1994-10-24
KR100315618B1 (ko) 2002-02-28
DK0691843T3 (da) 1997-04-28

Similar Documents

Publication Publication Date Title
EP1121104B1 (en) New controlled release oral formulations for rivastigmine
US20090124702A1 (en) Pharmaceutical Compositions of Metformin
EP2373319B1 (en) Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
US9387166B2 (en) Controlled release oral dosage form comprising oxycodone
NZ572616A (en) Stabilized pharmaceutical compositions comprising fesoterodine
RU2352338C2 (ru) Лекарственная композиция, содержащая флупиртин, с контролируемым высвобождением биологически активного вещества
FI114610B (fi) Menetelmä beta-fenyylipropiofenonijohdannaisia sisältävien retardmikrotablettien valmistamiseksi
SK3722001A3 (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
AU2004315136B2 (en) Extended release coated microtablets of venlafaxine hydrochloride
WO2005084636A2 (en) A process for the preparation of controlled-release pharmaceutical composition of metoprolol
SK284552B6 (sk) Trojvrstvová tableta s riadeným uvoľňovaním účinnej zložky na orálne podávanie
SK286651B6 (sk) Perorálna kompozícia s riadeným uvoľňovaním
US20090263481A1 (en) Levetiracetam formulations
Giunchedi et al. Hydrophilic matrices for the extended release of a model drug exhibiting pH-dependent solubility
CA2437412C (en) Delayed release microtablet of b-phenylpropiophenone derivatives
JP2009525953A (ja) ジバルプロ酸及びその誘導体の徐放性製剤
SK11072000A3 (sk) Tiagabínové prostriedky s predĺženým uvoľňovaním so zníženými vedľajšími účinkami
MC MK et al. preparation thereof
HU230983B1 (hu) Módosított hatóanyag-leadású gyógyszerkészítmény

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114610

Country of ref document: FI

MA Patent expired